Highbridge Capital Management »

Trisalus Life Sciences shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 215k 5.52

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Firstenergy Corp Bond (Principal)
American Airlines Group Bond (Principal)
Southern Bond (Principal)
Southwest Airls Bond (Principal)
Airbnb Bond (Principal)
Liberty Broadband Corp Common (LBRDK)
Hess Corp Common (HES)
Sarepta Therapeutics Bond (Principal)
Nice Bond (Principal)
Ventas Rlty Ltd Partnership Bond (Principal)
Dexcom Bond (Principal)
Guess Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Trisalus Life Sciences

Duquesne Family Office
Vanguard Group
Highbridge Capital Management
Exos Asset Management
Geode Capital Management
Millennium Management
Lido Advisors
Wolverine Asset Management
Hrt Financial
Connecticut Wealth Management
BlackRock
Goldman Sachs Group
Cambridge Investment Research Advisors
State Street Corporation
Tower Research Capital

View all funds holding Trisalus Life Sciences